Print

From the British Medical Journal Tobacco Control Blog: Philip Morris and the Government of Canada collaborate on COVID-19 vaccine development

Excerpts: "The vaccine developer at the middle of the controversy—Quebec-based Medicago Inc.—is owned by two major foreign shareholders including Philip Morris Investments (PMI) and Mitsubishi Tanabe Pharma. PMI owns one-third of Medicago and its former vice-president of regulatory affairs is the President and CEO of the vaccine developer. PMI has reported investing an undisclosed sum in the development of the new vaccine."

"The government has over 50 vaccine candidates to choose from globally—including several in Canada—so there is no lack of 'clean' investment options.

"By collaborating with Philip Morris on its own vaccine candidate, the Government of Canada is demonstrating complete disregard for its treaty obligations under the Framework Convention for Tobacco Control. Moreover, the government appears to be turning a blind eye to the tobacco industry and the pandemic of eight million deaths annually that it is fueling."